MODERN POSSIBILITIES OF COMBINED THERAPY OF EXTERNAL OTITIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article deals with modern concepts of the etiology, pathogenesis and treatment of external otitis. The authors discuss the most frequent causes of the development of diseases of the external ear, and the main nosological forms. The role of individual microorganisms in the genesis of the disease, the relationship of the type of pathogen, its biological properties and the nature of the course of inflammation are described in detail. The authors consider the possibilities of therapy of external otites taking into account the expected type of pathogen. The prospects of using topical therapy, the place of combined drugs in the treatment of acute and chronic diseases of the external ear are discussed. Authors’ own clinical experience of the effective use of a combination drug containing gentamicin, mometasone, econazole and dexpanthenol in the form of a cream is presented. The authors conclude that topical therapy for external otitis with combined drug containing gentamicin, mometasone, econazole and dexpanthenol is reasonable.

Full Text

Restricted Access

About the authors

A. V Gurov

Russian National Research Medical University n.a. N.I. Pirogov

Email: alex9999@inbox.ru
MD, Prof. at the Department of Otorhinolaryngology of the Medical Faculty

M. A Yushkina

Russian National Research Medical University n.a. N.I. Pirogov

Department of Otorhinolaryngology of the Medical Faculty

K. V Storozheva

St. Petersburg State University

References

  1. Плужников М.С., Лавренова Г.В., Дискаленко В.В. Заболевания наружного уха. СПб., 2000. 88 с.
  2. Косяков С.Я., Курлова А.В. Воспалительные заболевания наружного слухового прохода и методы их лечения. Вест, оториноларингологии. 2011;1:81-4.
  3. Поливода А.М. Воспалительные заболевания наружного уха. Вест. оториноларингологии. 2006;3:63-6.
  4. Martin T.J., Kerschner J.E., Flanary V.A. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int. J. Pediat. Otorhinolaryngol. 2005;28:33.
  5. Sood S., Strachan D.R., Tsikoudas A., Stables G.I. Allergic otitis externa. Clin. Otolaryngol. Allied. Sci. 2002;27(4):233-36.
  6. Кустов М.О. Микрофлора наружного слухового прохода у больных бактериальным наружным диффузным отитом. Росс. оториноларингология. 2012;3:66-70.
  7. Бирюкова Е.В., Гуров А.В., Юшкина М.А. Современные проблемы диагностики и лечения гнойно-воспалительных заболеваний ЛОР-органов у больных сахарным диабетом. Вест, оториноларингологии. 2011;2:76-9.
  8. Meltzer P.E., Kelemen G. Pyocyaneous osteomyelitis of the temporal bone, mandible and zygoma. Laryngoscope. 1959; 169:1300-16.
  9. Гуров А.В., Юшкина М.А. Особенности клинического течения и этиотропной терапии наружного отита. РМЖ. 2016;21:1426-31.
  10. Stroman D.W., Roland P.S., Dohar J., Burt W. Microbiology of normal external auditory canal. Laryngoscope. 2001;111(11 Pt. 1):2054-59.
  11. Федорова О.В., Шадрин Г.Б. Современный взгляд на лечение диффузного наружного отита. Вест. оториноларингологии. 2016;81(3):51-3.
  12. Оториноларингология. Клинические рекомендации / Под ред. В.Т. Пальчуна, А.И. Крюкова. М., 2013. 368 с.
  13. Akdis C.A., Akdis M., Bieber T., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/ PRACTALL Consensus Report. Allergy. 2006;61:969-87.
  14. Szczepanowska J., Reich A., Szepietowski J.C. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr. Allergy Immunol. 2008;19:614-18.
  15. Goujon C., Alleaume B., De Bony R., Girard P. Randomised single-blind pilot comparison study of the efficacy and tolerability of Bepanten ointment in subjects with bilateral dryness of the hands. Realitees Therapeutiques en Dermato-Venerologie. 1997;66:47-33.
  16. Gehring W., Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of human in vivo study. Arzneimittelforsch. 2000; 50:659-63.
  17. Camargo F.B., Gaspar L.R., Maia Campos PM. Skin moisturizing effects of panthenol-based formulations. J. Cosmet Sci 2011;62:361-70.
  18. Proksch E., Nissen H.P Dexpanthenol enhances skin barrier repair and redusec inflammation after sodiom lauryl sulphate-induced irritation. J. Dermatolog. Treat. 2002;13:173-78.
  19. Biro K., Thaci I.D., Ochsendorf F.R., et al. Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis. 2003;49:80-4.
  20. Ebner F., Heller A., Rippke F., Tausch I. Topical use of dexpanthenol in skin disorders. Am. J. Clin. Dermatol. 2002;3:427-33.
  21. Bahmer F., Pigatto P, Wehmeyer A. Adjuvante Hautpflege mit den dexpanthenolhaltigen Formen von pH5-Eucerin. Dtsch Derm. 1997;45(4):366-73.
  22. Wiederholt T., Heise R., Skazik C., Marquardt Y., Joussen S., Erdmann K., Schroder H., Merk H.F., Baron J.M. Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp. Dermatol. 2009:18:969-78.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies